High Expression of Human 15-Lipoxygenase Induces NF-κB-Mediated Expression of Vascular Cell Adhesion Molecule 1, Intercellular Adhesion Molecule 1, and T-Cell Adhesion on Human Endothelial Cells

Antioxidants and Redox Signaling

Volumn 1, Issue 1, 1999, Pages 83-96

  Viita, Helena ^a   Sen, Chandan K ^a,b   Roy, Sashwati ^a,b   Siljamäki, Tarja ^a   Nikkari, Tapio ^c   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

SIGANUS; UNIDENTIFIED RETROVIRUS;

ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; ENZYME INHIBITOR; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; OXIDIZING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; THAPSIGARGIN; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTERIOSCLEROSIS; ARTICLE; CELL ADHESION; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOBLOTTING; LEUKEMIA CELL LINE; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ARACHIDONATE 15-LIPOXYGENASE; ARTERIOSCLEROSIS; CELL ADHESION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; HYDROGEN PEROXIDE; IMMUNOBLOTTING; INTERCELLULAR ADHESION MOLECULE-1; JURKAT CELLS; NF-KAPPA B; OXIDANTS; RNA, MESSENGER; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; THAPSIGARGIN; THIOCTIC ACID; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033086392     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.1999.1.1-83     Document Type: Article

References (64)

1. ALBELDA, S.M. (1991). Endothelial and epithelial cell adhesion molecules. Am. J. Respir. Cell. Mol. Biol. 4, 195-203.
2. ANDALIBI, A., LIAO, F., IMES, S., FOGELMAN, A.M., and LUSIS, A.J. (1993). Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem. Soc. Trans. 21, 651-655.
3. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1992). Current Protocols in Molecular Biology. (Greene Publishing Associates and Wiley-Interscience, John Wiley & Sons, New York).
4. BAEUERLE, P.A., and HENKEL, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
5. BECK, E., LUDWIG, G., AUERSWALD, E.A., REISS, B., and SCHALLER, H. (1982). Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 19, 327-336.
6. BENZ, D.J., MOL, M., EZAKI, M., MORI-ITO, N., ZELÁN, I., MIYANOHARA, A., FRIEDMANN, T., PARTHASARATHY, S., STEINBERG, D., and WITZTUM, J.L. (1995). Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270, 5191-5197.
7. BOCAN, T.M.A., ROSEBURY, W.S., BAK MUELLER, S., KUCHERA, S., WELCH, K., DAUGHERTY, A., and CORNICELLI, J.A. (1998). A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 136, 203-216.
8. BRAND, K., PAGE, S., ROGLER, G., BARTSCH, A., BRANDL, R., KNUECHEL, R., PAGE, M., KALTSCHMIDT, C., BAEUERLE, P.A., and NEUMEIER, D. (1996). Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97, 1715-1722.
9. CAMACHO, M., GODESSART, N., ANTON, R., GARCIA, M., and VILA, L. (1995). Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270, 17279-17286.
10. CYBULSKY, M.I., and GIMBRONE, M.A. Jr. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
11. DERIAN, C.K., and LEWIS, D.F. (1992). Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein. Prostagland. Leukotrien. Essent. Fatty Acids. 45, 49-57.
12. GILBOA, E., EGLITIS, M.A., KANTOFF, P.W., and ANDERSON, W.F. (1986). Transfer and expression of cloned genes using retroviral vectors. BioTechniques 4, 504-512.
13. HARATS, D., KURIHARA, H., LEVKOVITZ, H., SHAISH, A., and SIGAL, E. (1997). 15-lipoxygenase overexpression induces atherosclerosis in LDL deficient mice. Atherosclerosis 134, 279.
14. HILTUNEN, T., LUOMA, J., NIKKARI, T., and YLÄ-HERTTUALA, S. (1995). Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 92, 3297-3303.
15. KALNINS, A., OTTO, K., RÜTHER, U., and MÜLLER-HILL, B. (1983). Sequence of the lacZ gene of Escherichia coli. EMBO J. 2, 593-597.
16. KHAN, B.V., PARTHASARATHY, S.S., ALEXANDER, R.W., and MEDFORD, R.M. (1995). Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95, 1262-1270.
17. KÜHN, H., BARNETT, J., GRUNBERGER, D., BAECKER, P., CHOW, J., NGUYEN, B., BURSZTYN-PETTEGREW, H., CHAN, H., and SIGAL, E. (1993). Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim. Biophys. Acta 1169, 80-89.
18. KÜHN, H., BELKNER, J., ZAISS, S., FÄHRENKLEMPER, T., and WOHLFEIL, S. (1994). Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179, 1903-1911.
19. KÜHN, H., HEYDECK, D., HUGOU, I., and GNIWOTTA, C. (1997). In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J. Clin. Invest. 99, 888-893.
20. LI, H., CYBULSKY, M.I., GIMBRONE, M.A., Jr., and LIBBY, P. (1993a). An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13, 197-204.
21. LI, H., CYBULSKY, M.I., GIMBRONE, M.A. Jr., and LIBBY, P. (1993b). Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am. J. Pathol. 143, 1551-1559.
22. LIAO, F., ANDALIBI, A., DEBEER, F.C., FOGELMAN, A.M., and LUSIS, A.J. (1993). Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91, 2572-2579.
23. LIAO, F., ANDALIBI, A., QIAO, J-H., ALLAYEE, H., FOGELMAN, A.M., and LUSIS, A.J. (1994). Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94, 877-884.
24. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L., and RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. MAKGOBA, M.W., SANDERS, M.E., LUCE, G.E.G., DUSTIN, M.L., SPRINGER, T.A., CLARK, E.A., MANNONI, P., and SHAW, S. (1988). ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 331, 86-88.
26. MANN, R., MULLIGAN, R.C., and BALTIMORE, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
27. McNALLY, A.K., CHISOLM III, G.M., MOREL, D.W., and CATHCART, M.K. (1990). Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J. Immunol. 145, 254-259.
28. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
29. MIYANOHARA, A., SHARKEY, M.F., WITZTUM, J.L., STEINBERG, D., and FRIEDMANN, T. (1988). Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 85, 6538-6542.
30. NAGY, L., TONTONOZ, P., ALVAREZ, J.G.A., CHEN, H., and EVANS, R.M. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARy. Cell 93, 229-240.
31. NIKKARI, T., MALO-RANTA, U., HILTUNEN, T., JAAKKOLA, O., and YLÄ-HERTTUALA, S. (1995). Monitoring of lipoprotein oxidation by gas chromatographic analysis of hydroxy fatty acids. J. Lipid. Res. 36, 200-207.
32. O'BRIEN, K.D., ALLEN, M.D., McDONALD, T.O., CHAIT, A., HARLAN, J.M., FISHBEIN, D., McCARTY, J., FERGUSON, M., HUDKINS, K., BENJAMIN, C.D., LOBB, R., and ALPERS, C.E. (1993). Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 92, 945-951.
33. PARTHASARATHY, S., WIELAND, E., and STEINBERG, D. (1989). A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA 86, 1046-1050.
34. POBER, J.S., GIMBRONE, M.A. Jr., LAPIERRE, L.A., MENDRICK, D.L., FIERS, W., ROTHLEIN, R., and SPRINGER, T.A. (1986). Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137, 1893-1896.
35. POSTON, R.N., HASKARD, D.O., COUCHER, J.R., GALL, N.P., and JOHNSON-TIDEY, R.R. (1992). Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140, 665-673.
36. PRINTSEVA, O.Y., PECLO, M.M., and GOWN, A.M. (1992). Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am. J. Pathol. 140, 889-896.
37. RANKIN, S.M., PARTHASARATHY, S., and STEINBERG, D. (1991). Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32, 449-456.
38. RICE, C.E., and BEVILACQUA, M.P. (1989). An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246, 1303-1306.
39. RICE, G.E., MUNRO, J.M., and BEVILACQUA, M.P. (1990). Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J. Exp. Med. 171, 1369-1374.
40. ROEBUCK, K.A., RAHMAN, A., LAKSHMINARAYANAN, V., JANAKIDEVI, K., and MALIK, A.B. (1995). H202 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270, 18966-18974.
41. ROSS, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 372, 801-809.
42. ROY, S., SEN, C.K., KOBUCHI, H., and PACKER, L. (1998). Antioxidant regulation of phorbol ester-induced adhesion of human jurkat T-cells to endothelial cells. Free Radic. Biol. Med. 25, 229-241.
43. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
44. SCHRECK, R., ALBERMANN, K., and BAEUERLE, P.A. (1992). Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad. Res. Comms. 17, 221-237.
45. SEN, C.K., and PACKER, L. (1996). Antioxidant and redox regulation of gene transcription. FASEB J. 10, 709-720.
46. SEN, C.K., TRABER, K.E., and PACKER, L. (1996a). Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione. Biochim. Biophys. Res. Commun. 218, 148-153.
47. 2+ in oxidant-induced NF-kappa B activation. FEBS Lett. 385, 58-62.
48. SENDOBRY, S.M., CORNICELLI, J.A., WELCH, K., BOCAN, T., TAIT, B., TRIVEDI, B.K., COLBRY, N., DYER, R.D., FEINMARK, S.J., and DAUGHERTY, A. (1997). Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br. J. Pharm. 120, 1199-1206.
49. SHARKEY, M.F., MIYANOHARA, A., ELAM, R.L., FRIEDMANN, T., and WITZTUM, J.L. (1990). Posttranscriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity. J. Lipid Res. 31, 2167-2178.
50. SHEN, J., HERDERICK, E., CORNHILL, J.F., ZSIGMOND, E., KIM, H-S., KÜHN, H., GUEVARA, N.V., and CHAN, L. (1996). Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J. Clin. Invest. 98, 2201-2208.
51. SIGAL, E. (1991). The molecular biology of mammalian arachidonic acid metabolism. Am. J. Physiol. 260, L13-L28.
52. SIGAL, E., CRAIK, C.S., HIGHLAND, E., GRUNBERGER, D., COSTELLO, L.L., DIXON, R.A.F., and NADEL, J.A. (1988). Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Biophys. Res. Commun. 157, 457-464.
53. SIGAL, E., GRUNBERGER, D., HIGHLAND, E., GROSS, C., DIXON, R.A.F., and CRAIK, C.S. (1990). Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related. J. Biol. Chem. 265, 5113-5120.
54. SPARROW, C.P., and OLSZEWSKI, J. (1992). Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Proc. Natl. Acad. Sci. USA 89, 128-131.
55. SPARROW, C.P., PARTHASARATHY, S., and STEINBERG, D. (1988). Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J. Lipid Res. 29, 745-753.
56. SULTANA, C., SHEN, Y., RATTAN, V., and KALRA, V.K. (1996). Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. J. Cell. Physiol. 167, 477-487.
57. SUN, D., and FUNK, C.D. (1996). Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. J. Biol. Chem. 271, 24055-24062.
58. VAN BEVEREN, C., GODDARD, J.G., BERNS, A., and VERMA, I.M. (1980). Structure of Moloney murine leukemia viral DNA: Nucleotide sequence of the 5′ long terminal repeat and adjacent cellular sequences. Proc. Natl. Acad. Sci. USA 77, 3307-3311.
59. WÖLLE, J., WELCH, K.A., DEVALL, L.J., CORNICELLI, J.A., and SAXENA, U. (1996). Transient overexpression of human 15-lipoxygenase in aortic endothelial cells enhances tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression. Biochim. Biophys. Res. Commun. 220, 310-314.
60. YLÄ-HERTTUALA, S. (1998). Is oxidized low-density lipoprotein present in vivo? Curr. Opin. Lipidol. 9, 337-344.
61. YLÄ-HERTTUALA, S., PALINSKI, W., ROSENFELD, M.E., PARTHASARATHY, S., CAREW, T.E., BUTLER, S., WITZTUM, J.L., and STEINBERG, D. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.
62. YLÄ-HERTTUALA, S., ROSENFELD, M.E., PARTHASARATHY, S., GLASS, C.K., SIGAL, E., WITZTUM, J.L., and STEINBERG, D. (1990). Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87, 6959-6963.
63. YLÄ-HERTTUALA, S., ROSENFELD, M.E., PARTHASARATHY, S., SIGAL, E., SARKIOJA, T., WITZTUM, J.L., and STEINBERG, D. (1991). Gene expression in macrophage-rich human atherosclerotic lesions. J. Clin. Invest. 87, 1146-1152.
64. YLÄ-HERTTUALA, S., LUOMA, J., VIITA, H., HILTUNEN, T., SISTO, T., and NIKKARI, T. (1995). Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 95, 2692-2698.